TI
STIM icon

Trexquant Investment’s Neuronetics STIM Stock Holding History

Trexquant Investment’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,792
Closed -$143K – 1604
2021
Q3 		$143K Buy
21,792
+4,422
+25% +$42.4K 0.01% 1016
2021
Q2 		$278K Buy
+17,370
New +$240K 0.02% 747
2020
Q1 		– Sell
-51,896
Closed -$233K – 1400
2019
Q4 		$233K Buy
51,896
+39,569
+321% +$246K 0.01% 854
2019
Q3 		$102K Buy
+12,327
New +$135K 0.01% 811

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Trexquant Investment's STIM Position: Q4 2021 in Review

Trexquant Investment sold out of Neuronetics (STIM) in Q4 2021, closing a stake of 21,792 shares — an estimated $143K sold.

Trexquant Investment first reported a position in STIM in Q3 2019 and held it in 4 quarters. The position peaked at $278K in Q2 2021. 80 funds tracked by Wall St. Rank hold STIM as of Q4 2021.

  • Trexquant Investment reported no remaining Neuronetics position as of Q4 2021 after selling out during the quarter.
  • Trexquant Investment sold 21,792 Neuronetics shares in Q4 2021, an estimated $143K.
  • Trexquant Investment first reported a position in Neuronetics in Q3 2019 and held it in 4 quarters.
  • Trexquant Investment's Neuronetics position peaked at $278K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Neuronetics as of Q4 2021.

Based on Trexquant Investment's 13F filing for Q4 2021, filed 14 Feb 2022.